If a variant has more than one submission, it may be counted in more than one significance column. If this is the
case, the total number of variants will be less than the sum of the other cells.
| pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
association |
established risk allele |
likely pathogenic, low penetrance |
likely risk allele |
pathogenic, low penetrance |
risk factor |
not provided |
total |
|
855
|
451
|
2265
|
1170
|
413
|
1
|
3
|
1
|
3
|
2
|
1
|
58
|
4424
|
Condition and significance breakdown #
| Condition |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
association |
established risk allele |
likely pathogenic, low penetrance |
likely risk allele |
pathogenic, low penetrance |
risk factor |
not provided |
total |
|
Familial cancer of breast
|
709
|
314
|
1759
|
841
|
358
|
0 |
1
|
0 |
0 |
2
|
0 |
1
|
3568
|
|
Hereditary cancer-predisposing syndrome
|
318
|
157
|
1411
|
599
|
11
|
0 |
3
|
0 |
3
|
0 |
0 |
0 |
2381
|
|
not provided
|
87
|
116
|
489
|
119
|
58
|
0 |
0 |
0 |
0 |
0 |
1
|
29
|
800
|
|
not specified
|
2
|
0 |
197
|
209
|
25
|
0 |
0 |
0 |
0 |
0 |
0 |
10
|
411
|
|
CHEK2-related cancer predisposition
|
22
|
33
|
94
|
12
|
10
|
0 |
1
|
0 |
0 |
0 |
0 |
21
|
162
|
|
Hereditary breast ovarian cancer syndrome
|
28
|
37
|
30
|
10
|
12
|
0 |
1
|
1
|
0 |
0 |
0 |
0 |
113
|
|
CHEK2-related disorder
|
9
|
8
|
68
|
21
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
106
|
|
CHEK2-related cancer predisposition; Bone osteosarcoma; Familial prostate cancer
|
15
|
16
|
47
|
6
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
83
|
|
Malignant tumor of breast
|
11
|
8
|
50
|
10
|
3
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
82
|
|
Breast and/or ovarian cancer
|
8
|
14
|
36
|
11
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
70
|
|
Hereditary nonpolyposis colon cancer
|
6
|
4
|
27
|
11
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
48
|
|
Familial cancer of breast; CHEK2-related cancer predisposition; Bone osteosarcoma; Prostate cancer
|
7
|
1
|
29
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
37
|
|
Familial cancer of breast; CHEK2-related cancer predisposition; Bone osteosarcoma; Prostate cancer; Colorectal cancer
|
2
|
2
|
18
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
23
|
|
Predisposition to cancer
|
5
|
5
|
12
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
23
|
|
Gastric cancer
|
19
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
19
|
|
Li-Fraumeni syndrome
|
3
|
2
|
6
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
13
|
|
Breast and colorectal cancer, susceptibility to
|
5
|
5
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
12
|
|
Prostate cancer
|
5
|
1
|
5
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
11
|
|
Breast carcinoma
|
5
|
4
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
10
|
|
Breast-ovarian cancer, familial, susceptibility to, 1
|
7
|
0 |
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
9
|
|
Colorectal cancer
|
5
|
1
|
3
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
9
|
|
Familial prostate cancer
|
1
|
0 |
7
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
9
|
|
Hereditary cancer
|
0 |
0 |
1
|
6
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
8
|
|
Inherited breast cancer and ovarian cancer
|
3
|
3
|
3
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
8
|
|
Breast neoplasm
|
3
|
2
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
7
|
|
CHEK2-related cancer predisposition; Familial prostate cancer
|
2
|
0 |
4
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
7
|
|
Familial ovarian cancer
|
1
|
0 |
5
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
6
|
|
Bone osteosarcoma
|
3
|
1
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
5
|
|
Breast cancer, susceptibility to; Prostate cancer susceptibility
|
1
|
4
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
5
|
|
Carcinoma of pancreas
|
3
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
4
|
|
Endometrial carcinoma
|
2
|
0 |
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
4
|
|
Familial cancer of breast; CHEK2-related cancer predisposition
|
4
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
4
|
|
Breast cancer, susceptibility to
|
3
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3
|
|
Li-Fraumeni syndrome 1
|
1
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3
|
|
Li-Fraumeni syndrome; Hereditary breast ovarian cancer syndrome; Familial colorectal cancer type X
|
0 |
0 |
2
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3
|
|
See cases
|
0 |
2
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3
|
|
Carcinoma of colon
|
0 |
0 |
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2
|
|
Familial cancer of breast; CHEK2-related cancer predisposition; Bone osteosarcoma; Familial prostate cancer
|
1
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2
|
|
Familial cancer of breast; CHEK2-related cancer predisposition; Bone osteosarcoma; Familial prostate cancer; Colorectal cancer
|
0 |
1
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2
|
|
Familial cancer of breast; Familial prostate cancer
|
0 |
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2
|
|
Familial cancer of breast; Prostate cancer; Colorectal cancer
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
2
|
|
TUMOR PREDISPOSITION SYNDROME 4, BREAST
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2
|
|
TUMOR PREDISPOSITION SYNDROME 4, BREAST/PROSTATE
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2
|
|
TUMOR PREDISPOSITION SYNDROME 4, BREAST/PROSTATE/COLORECTAL
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2
|
|
Astrocytoma
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Breast neoplasm; Leiomyosarcoma
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
CHEK2-related cancer risk
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Colon cancer
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Colonic neoplasm
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Congenital heart defects, multiple types, 3
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Diffuse midline glioma, H3 K27-altered
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Familial cancer of breast; CHEK2-related cancer predisposition; Hereditary breast ovarian cancer syndrome
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Familial cancer of breast; Colorectal cancer
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
1
|
|
Familial cancer of breast; Familial prostate cancer; Colorectal cancer
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Familial cancer of breast; Lung carcinoma; Prostate cancer; Carcinoma of colon
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Familial cancer of breast; Ovarian neoplasm; Lung cancer
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Gastrointestinal carcinoma; Adrenal cortex carcinoma
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Incidental Discovery
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Inherited prostate cancer
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Li-Fraumeni syndrome; Familial colorectal cancer type X
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Li-Fraumeni syndrome; Hereditary breast ovarian cancer syndrome
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Lynch syndrome 1
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Malignant lymphoma, large B-cell, diffuse
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Melanoma
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
NICE approved PARP inhibitor treatment
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
NK-cell enteropathy
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Nephroblastoma
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Ovarian carcinoma
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Ovarian neoplasm
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Premature ovarian failure
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Prostate cancer, somatic
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Sarcoma
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Triple-negative breast cancer
|
0 |
0 |
0 |
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Uterine corpus cancer
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
Submitter and significance breakdown #
| Submitter |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
association |
established risk allele |
likely pathogenic, low penetrance |
likely risk allele |
pathogenic, low penetrance |
risk factor |
not provided |
total |
|
Labcorp Genetics (formerly Invitae), Labcorp
|
566
|
175
|
1699
|
730
|
23
|
0 |
0 |
0 |
0 |
2
|
0 |
0 |
3195
|
|
Ambry Genetics
|
297
|
118
|
1235
|
432
|
5
|
0 |
3
|
0 |
0 |
0 |
0 |
0 |
2090
|
|
Myriad Genetics, Inc.
|
315
|
134
|
66
|
218
|
341
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1074
|
|
Color Diagnostics, LLC DBA Color Health
|
79
|
48
|
509
|
266
|
8
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
910
|
|
GeneDx
|
41
|
79
|
391
|
176
|
66
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
753
|
|
Baylor Genetics
|
47
|
83
|
246
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
376
|
|
Department of Pathology and Laboratory Medicine, Sinai Health System
|
34
|
16
|
165
|
45
|
4
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
264
|
|
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
|
31
|
22
|
146
|
51
|
9
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
259
|
|
Quest Diagnostics Nichols Institute San Juan Capistrano
|
32
|
26
|
152
|
28
|
8
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
246
|
|
Counsyl
|
5
|
30
|
100
|
26
|
4
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
165
|
|
Sema4, Sema4
|
11
|
17
|
100
|
31
|
3
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
162
|
|
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
|
7
|
13
|
68
|
59
|
3
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
150
|
|
PreventionGenetics, part of Exact Sciences
|
8
|
9
|
73
|
27
|
6
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
123
|
|
Fulgent Genetics, Fulgent Genetics
|
12
|
15
|
87
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
115
|
|
CeGaT Center for Human Genetics Tuebingen
|
18
|
20
|
44
|
28
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
111
|
|
Mendelics
|
8
|
15
|
60
|
24
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
108
|
|
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario
|
6
|
10
|
36
|
11
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
65
|
|
Genetic Services Laboratory, University of Chicago
|
5
|
1
|
38
|
11
|
2
|
0 |
0 |
0 |
0 |
0 |
1
|
0 |
58
|
|
Illumina Laboratory Services, Illumina
|
3
|
8
|
30
|
2
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
44
|
|
German Consortium for Hereditary Breast and Ovarian Cancer, University Hospital Cologne
|
2
|
17
|
16
|
3
|
3
|
0 |
1
|
1
|
0 |
0 |
0 |
0 |
43
|
|
KCCC/NGS Laboratory, Kuwait Cancer Control Center
|
6
|
3
|
26
|
2
|
8
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
43
|
|
Institute of Human Genetics, University of Leipzig Medical Center
|
9
|
12
|
19
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
39
|
|
Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden
|
6
|
7
|
22
|
1
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
37
|
|
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
|
6
|
2
|
18
|
8
|
3
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
37
|
|
MGZ Medical Genetics Center
|
6
|
8
|
19
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
33
|
|
GeneKor MSA
|
5
|
7
|
20
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
33
|
|
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
|
5
|
4
|
19
|
4
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
33
|
|
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
|
6
|
4
|
10
|
7
|
4
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
31
|
|
Revvity Omics, Revvity
|
14
|
5
|
12
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
31
|
|
University of Washington Department of Laboratory Medicine, University of Washington
|
4
|
5
|
2
|
20
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
31
|
|
Institute for Biomarker Research, Medical Diagnostic Laboratories, L.L.C.
|
2
|
5
|
15
|
5
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
29
|
|
Mayo Clinic Laboratories, Mayo Clinic
|
5
|
4
|
18
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
27
|
|
Clinical Genetics Laboratory, Department of Pathology, Netherlands Cancer Institute
|
2
|
3
|
10
|
7
|
4
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
26
|
|
Genome Diagnostics Laboratory, Amsterdam University Medical Center
|
5
|
1
|
10
|
5
|
3
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
24
|
|
GenomeConnect - Invitae Patient Insights Network
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
24
|
24
|
|
St. Jude Molecular Pathology, St. Jude Children's Research Hospital
|
5
|
5
|
12
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
23
|
|
Clinical Genetics Laboratory, Skane University Hospital Lund
|
12
|
3
|
8
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
23
|
|
Molecular Diagnostics Laboratory, Catalan Institute of Oncology
|
2
|
11
|
7
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
22
|
|
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
|
2
|
3
|
9
|
7
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
21
|
|
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
|
3
|
3
|
10
|
5
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
21
|
|
National Health Laboratory Service, Universitas Academic Hospital and University of the Free State
|
2
|
0 |
4
|
5
|
9
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
20
|
|
Institute. of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University in Prague
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
19
|
19
|
|
Genetics and Molecular Pathology, SA Pathology
|
7
|
3
|
9
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
19
|
|
Laboratory for Genotyping Development, RIKEN
|
19
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
19
|
|
Breakthrough Genomics, Breakthrough Genomics
|
0 |
0 |
1
|
7
|
9
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
17
|
|
Human Genome Sequencing Center Clinical Lab, Baylor College of Medicine
|
10
|
6
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
16
|
|
OMIM
|
12
|
0 |
3
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
15
|
|
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen
|
6
|
9
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
15
|
|
Cancer Genomics Group, Japanese Foundation For Cancer Research
|
0 |
1
|
13
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
15
|
|
Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet
|
2
|
5
|
4
|
0 |
0 |
0 |
0 |
0 |
3
|
0 |
0 |
0 |
14
|
|
BRCAlab, Lund University
|
9
|
5
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
14
|
|
Centre for Mendelian Genomics, University Medical Centre Ljubljana
|
5
|
3
|
4
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
12
|
|
GenomeConnect, ClinGen
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
12
|
12
|
|
CZECANCA consortium
|
7
|
5
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
12
|
|
Division of Medical Genetics, University of Washington
|
1
|
1
|
10
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
12
|
|
Medical Genetics Laboratory, Umraniye Training and Research Hospital, University of Health Sciences
|
6
|
5
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
12
|
|
ITMI
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
10
|
10
|
|
True Health Diagnostics
|
3
|
3
|
2
|
1
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
10
|
|
Zotz-Klimas Genetics Lab, MVZ Zotz Klimas
|
2
|
3
|
4
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
9
|
|
Neuberg Centre For Genomic Medicine, NCGM
|
0 |
0 |
9
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
9
|
|
Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center
|
5
|
3
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
8
|
|
Department of Molecular Diagnostics, Institute of Oncology Ljubljana
|
5
|
2
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
8
|
|
King Laboratory, University of Washington
|
5
|
0 |
0 |
0 |
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
7
|
|
Genome Diagnostics Laboratory, University Medical Center Utrecht
|
4
|
0 |
1
|
1
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
7
|
|
Knight Diagnostic Laboratories, Oregon Health and Sciences University
|
3
|
4
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
7
|
|
Department of Genetics, HCU Lozano Blesa
|
0 |
5
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
7
|
|
Genomic Research Center, Shahid Beheshti University of Medical Sciences
|
0 |
1
|
4
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
6
|
|
Center of Medical Genetics and Primary Health Care
|
1
|
3
|
2
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
6
|
|
Genomics and Molecular Medicine Service, East Genomic Laboratory Hub, NHS Genomic Medicine Service
|
1
|
2
|
3
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
6
|
|
Academic Department of Medical Genetics, University of Cambridge
|
2
|
3
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
5
|
|
Institute of Human Genetics, FAU Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg
|
3
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
5
|
|
Department of Pediatric Oncology, Hematology and Clinical Immunology, University Clinics Duesseldorf
|
0 |
0 |
5
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
5
|
|
Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein
|
1
|
1
|
2
|
0 |
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
5
|
|
Pathway Genomics
|
1
|
1
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
4
|
|
Clinical Genetics and Genomics, Karolinska University Hospital
|
2
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
4
|
|
Juno Genomics, Hangzhou Juno Genomics, Inc
|
3
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
4
|
|
DASA
|
1
|
3
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
4
|
|
Department of Human Genetics, Hannover Medical School
|
2
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
4
|
|
Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego
|
3
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3
|
|
3DMed Clinical Laboratory Inc
|
2
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3
|
|
Institute of Human Genetics, Heidelberg University
|
1
|
3
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3
|
|
AiLife Diagnostics, AiLife Diagnostics
|
2
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3
|
|
Molecular Oncology Research Center, Barretos Cancer Hospital
|
0 |
1
|
1
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3
|
|
Human Genetics Bochum, Ruhr University Bochum
|
2
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3
|
|
Institute of Immunology and Genetics Kaiserslautern
|
3
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3
|
|
Hereditary Cancer Laboratory, Hospital Universitario 12 de Octubre
|
1
|
0 |
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3
|
|
NHS Central & South Genomic Laboratory Hub
|
2
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3
|
|
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2
|
|
Eurofins Ntd Llc (ga)
|
1
|
0 |
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2
|
|
ISCA site 1
|
0 |
1
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2
|
|
HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology
|
1
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2
|
|
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
|
0 |
1
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2
|
|
Liquid Biopsy and Cancer Interception Group, Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research
|
1
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2
|
|
University Health Network, Princess Margaret Cancer Centre
|
0 |
1
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2
|
|
Clinical Genetics Laboratory, University Hospital Schleswig-Holstein
|
2
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2
|
|
Biomedical Genomics and Oncogenetics Laboratory, Institut Pasteur de Tunis, University Tunis El Manar
|
1
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2
|
|
Breast Care Center, Daerim St. Mary`s Hospital
|
1
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2
|
|
MVZ Medizinische Genetik Mainz
|
1
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2
|
|
Diagnostics Centre, Carl Von Ossietzky University Oldenburg
|
1
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2
|
|
Unidad de Genética Molecular HGU Elche, Hospital General Universitario de Elche
|
0 |
1
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2
|
|
Institute of Human Genetics, University of Goettingen
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Centogene AG - the Rare Disease Company
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Cambridge Genomics Laboratory, East Genomic Laboratory Hub, NHS Genomic Medicine Service
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Genetics and Personalized Medicine Clinic, Tartu University Hospital
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Center of Genomic medicine, Geneva, University Hospital of Geneva
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Molecular Oncology Laboratory, Centre Jean Perrin
|
0 |
0 |
0 |
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Genome Sciences Centre, British Columbia Cancer Agency
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Dr. Peter K. Rogan Lab, Western University
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Faculty of Pharmacy, Medical University of Gdansk
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Institute for Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Department of Molecular and Medical Genetics, Osaka Medical Center for Cancer and Cardiovascular Diseases
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Donald Williams Parsons Laboratory, Baylor College of Medicine
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Institute of Human Genetics, University of Wuerzburg
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Institute of Human Genetics, University Hospital of Duesseldorf
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Kasturba Medical College, Manipal, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
A.C.Camargo Cancer Center / LGBM, A.C.Camargo Cancer Center
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Department of Pediatrics, Memorial Sloan Kettering Cancer Center
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Center for Personalized Medicine, Children's Hospital Los Angeles
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Snyder Lab, Genetics Department, Stanford University
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Laboratory of Medical Genetics Unit, Bambino Gesù Children's Hospital
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Academic Center for Education, Culture and Research, Motamed Cancer Institute
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Laboratory of Molecular Neuropathology, The University of Texas Health Science Center at Houston
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
GeneID Lab - Advanced Molecular Diagnostics
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Medical Cytogenetics and Molecular Genetics Laboratory, IRCCS Istituto Auxologico Italiano
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Cancer Variant Interpretation Group UK, Institute of Cancer Research, London
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Genomic Medicine Lab, University of California San Francisco
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Genomic Diagnostics Laboratory, National Institute of Medical Genomics
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Xiao lab, Department of Pathology, Memorial Sloan Kettering Cancer Center
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Unit of Medical Genetics, Department of Laboratory Medicine, San Giovanni Calibita Fatebenefratelli Hospital
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Dr. med. U. Finckh, Human Genetics, Eurofins MVZ
|
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Division of Gastroenterology and Hepatology, Shanghai Institute of Digestive Disease, Shanghai Jiao Tong University School of Medicine.
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Francois Mercier Lab, McGill University
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Hauer Lab, Department Of Pediatric Oncology, Technical University Munich
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Genomics England Pilot Project, Genomics England
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Cancer Genomics Lab, PINUM Cancer Hospital
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Laboratory Cellgenetics, GMDL Cellgenetics
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Kong lab, Department of Laboratory Medicine, National Cancer Center
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Research Unit of Translational Medicine, University of Oulu
|
0 |
0 |
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Department Of Pathology & Laboratory Medicine, University Of Pennsylvania
|
0 |
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
|
Biotechnology, Institute of Science, Nirma University
|
1
|
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1
|
The information on this website is not intended for direct
diagnostic use or medical decision-making without review by a
genetics professional. Individuals should not change their
health behavior solely on the basis of information contained on
this website. Neither the University of Utah nor the National
Institutes of Health independently verfies the submitted
information. If you have questions about the information
contained on this website, please see a health care
professional.